Skip to main navigation Skip to search Skip to main content

CSF and plasma GFAP and VEGF in adult type 3 spinal muscular atrophy patients treated with nusinersen

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'CSF and plasma GFAP and VEGF in adult type 3 spinal muscular atrophy patients treated with nusinersen'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Neuroscience

Immunology and Microbiology